ZNF85
Zinc finger protein 85
Also known as: HPF4, HTF1, ZNF85_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q03923
- Gene
- ZNF85
- Ensembl
- ENSG00000105750
- Chromosome
- 19
- Canonical length
- 595 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
595 residues, UniProt reviewed canonical sequence.
>Q03923|ZNF85
1 MGPLTFRDVA IEFSLKEWQC LDTAQRNLYR NVMLENYRNL VFLGITVSKP DLITCLEQGK
61 EAWSMKRHEI MVAKPTVMCS HFAQDLWPEQ NIKDSFQKVT LKRYGKCRHE NLPLRKGCES
121 MDECKMHKGG CNGLNQCLTA TQSKIFQCDK YVKVAHKFSN SNRHEIRHTK KKPFKCTKCG
181 KSFGMISCLT EHSRIHTRVN FYKCEECGKA FNWSSTLTKH KRIHTGEKPY KCEECGKAFN
241 QSSNLIKHKK IHTGEKPYKC EECGKTFNRF STLTTHKIIH TGEKPYKCKE CGKAFNRSST
301 LTTHRKIHTG EKPYKCEECG KAFKQSSNLT THKIIHTGEK PYKCKKCGKA FNQSAHLTTH
361 EVIHTGEKPY KCEKCGKAFN HFSHLTTHKI IHTGEKPYKC KECGKAFKHS STLTKHKIIH
421 TGEKPYKCKE CEKAFNQSSK LTEHKKIHTG EKPYECEKCG KAFNQSSNLT RHKKSHTEEK
481 PYKCEECGKG FKWPSTLTIH KIIHTGEKPY KCEECGKAFN QSSKLTKHKK IHTGEKPYTC
541 EECGKAFNQS SNLTKHKRIH TGEKPYKCEE CDKAFKWSSV LTKHKIIHTG EKLQILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF85 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- testis: 10 nTPM
- pancreas: 7.2 nTPM
- thyroid gland: 7.2 nTPM
- ovary: 6.8 nTPM
- tonsil: 5.6 nTPM
- lymph node: 5.3 nTPM
Single-cell type
- microglia: 19 nCPM
- distal convoluted tubule cells: 18 nCPM
- oligodendrocyte progenitor cells: 17 nCPM
- renal collecting duct intercalated cells: 15 nCPM
- renal collecting duct principal cells: 15 nCPM
- renal connecting tubule cells: 13 nCPM
Immune cell
- memory B-cell: 5.4 nTPM
- NK-cell: 5.3 nTPM
- naive B-cell: 3.6 nTPM
- eosinophil: 2.8 nTPM
- T-reg: 2.8 nTPM
- naive CD4 T-cell: 2.6 nTPM
Brain region
- cerebellum: 9.8 nTPM
- white matter: 5.8 nTPM
- medulla oblongata: 5.3 nTPM
- midbrain: 5.3 nTPM
- pons: 5.2 nTPM
- cerebral cortex: 5.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZNF85.
Disease | AutoantibodyPubMed
Conditions in which antibodies against ZNF85 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for ZNF85 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
14 publications
- Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
1995 · Thromb Haemost · RCR 8.3 · 247 citations - Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
1996 · Blood · RCR 5.7 · 181 citations - Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
2000 · Blood · RCR 2.3 · 107 citations - Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices.
2000 · ASAIO J · RCR 1.2 · 36 citations - Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients.
2013 · Thromb Res · RCR 0.9 · 21 citations
Show 9 more
- The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes.
2004 · Blood · RCR 0.9 · 40 citations - Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia.
2003 · Blood Coagul Fibrinolysis · RCR 0.5 · 15 citations - A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis.
2006 · Am J Hematol · RCR 0.3 · 8 citations - Heparin: induced thrombocytopenia: incidence and laboratory approach to diagnosis in Indians.
2014 · Indian J Pathol Microbiol · RCR 0.3 · 6 citations - Heparin platelet factor 4 antibody positivity in pseudothrombocytopenia.
2012 · Clin Appl Thromb Hemost · RCR 0.3 · 4 citations - Detection and significance of heparin-platelet factor 4 antibodies.
2005 · Semin Hematol · RCR 0.2 · 6 citations - An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
2009 · Semin Thromb Hemost · RCR 0.1 · 4 citations - Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study.
2015 · Platelets · RCR 0.1 · 2 citations - Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates.
2000 · Thromb Res · RCR 0 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.87
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.45
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF85 as an antibody target. Whether an autoantibody or antibody against ZNF85 could matter depends on whether native ZNF85 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF85 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF85 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...